ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 890

$732K Total Retail Price of All Prescriptions

Rank: 128 out of 890

640 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

40% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 10,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 2,531 965 S3 1 3
CARISOPRODOL 941 122 R 2 69
LISINOPRIL 600 281 3 4
FUROSEMIDE 509 403 4 7
ZOLPIDEM TARTRATE 414 191 5 19
METFORMIN HCL 334 185 6 6
LEVOTHYROXINE SODIUM 303 232 7 2
SIMVASTATIN 301 252 8 5
OMEPRAZOLE 301 228 8 8
AMLODIPINE BESYLATE 286 199 10 1
METOPROLOL TARTRATE 267 167 11 15
POTASSIUM CHLORIDE 251 217 12 11
TRAMADOL HCL 248 170 13 16
MELOXICAM 240 161 14 18
CYCLOBENZAPRINE HCL 236 43 R 15 64
PRAVASTATIN SODIUM 224 131 16 10
CARVEDILOL 216 138 17 22
GABAPENTIN 210 100 18 12
NEXIUM 208 130 19 14
WARFARIN SODIUM 163 106 20 24
PAROXETINE HCL 163 120 20 68
ATENOLOL 160 68 22 23
SERTRALINE HCL 158 119 23 26
DONEPEZIL HCL 151 149 24 30
HYDROCHLOROTHIAZIDE 149 82 25 9
AMITRIPTYLINE HCL 134 91 R 26 43
ATORVASTATIN CALCIUM 129 76 27 13
TRAZODONE HCL 125 75 28 40
LYRICA 122 79 29 71
OXYCODONE HCL-ACETAMINOPHEN 122 27 S2 29 127
AZITHROMYCIN 116 79 31 37
PROMETHAZINE HCL 114 51 R 32 104
CLOPIDOGREL 110 84 33 28
CITALOPRAM HBR 107 59 34 20
ISOSORBIDE MONONITRATE ER 106 99 35 60
NAMENDA 104 104 36 36
METOPROLOL SUCCINATE 103 86 37 17
ENALAPRIL MALEATE 101 95 38 56
CLONIDINE HCL 96 64 39 35
TAMSULOSIN HCL 95 69 40 32
CIPROFLOXACIN HCL 94 59 41 58
PLAVIX 93 80 42 42
OXYBUTYNIN CHLORIDE 93 57 42 139
LOSARTAN POTASSIUM 87 78 44 29
QUETIAPINE FUMARATE 85 52 45 73
GLIPIZIDE 84 55 46 62
ESCITALOPRAM OXALATE 84 79 46 51
LANTUS 82 42 48 50
PANTOPRAZOLE SODIUM 80 65 49 34
METOLAZONE 79 48 50 217
HYDRALAZINE HCL 79 49 50 100
PHENYTOIN SODIUM EXTENDED 79 40 50 111
DILTIAZEM HCL 79 55 50 235
CYMBALTA 73 0 54 45
RANITIDINE HCL 72 24 55 49
NOVOLIN 70-30 71 66 56 199
IBUPROFEN 67 23 57 101
ALENDRONATE SODIUM 66 41 58 38
MEGESTROL ACETATE 64 57 R 59 92
NIFEDIPINE ER 63 40 60 75
ALLOPURINOL 63 51 60 31
ENDOCET 62 22 S2 62 218
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 38 63 76
CEPHALEXIN 58 38 64 119
CELEBREX 56 37 65 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 22 66 21
ROPINIROLE HCL 55 43 66 93
DICLOFENAC SODIUM 55 25 66 96
PROAIR HFA 54 13 69 55
NOVOLIN R 54 43 69 153
RISPERIDONE 54 40 69 78
TIZANIDINE HCL 53 0 72 106
GEMFIBROZIL 53 35 72 103
GLIMEPIRIDE 52 43 74 27
VENLAFAXINE HCL 52 17 74 287
FINASTERIDE 51 37 76 108
ZIPRASIDONE HCL 50 26 77 229
GLYBURIDE 50 33 R 77 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.